Funding and Investments

Apr 01, 2009
BioPharm International
By BioPharm International Editors
Big biotechs will do just fine in the ongoing financial crisis, but the smaller companies will have more difficulty weathering the storm.
Feb 01, 2009
BioPharm International
What the current lack of venture capital means for the CRO market.
Jan 01, 2009
BioPharm International
By BioPharm International Editors
Small biotechs were forced to restructure and downsize.
Dec 01, 2008
BioPharm International
By BioPharm International Editors
The meltdown in the financial markets represents a sea change in the world of financing that will continue to affect the flow of much needed capital into the sector for the foreseeable future.
Oct 01, 2008
BioPharm International
By BioPharm International Editors
The biotech industry's year-to-date report card contains good grades despite the turbulent economic climate.
Jun 10, 2008
By BioPharm International Editors
Health and Human Services Secretary Mike Leavitt has announced that his agency is amending its budget request for FY 2009 to include an additional $275 million for the FDA.
Jun 01, 2008
BioPharm International
By BioPharm International Editors
Following the market crisis of the first quarter of 2008, biotech IPOs and financing are down, but partnering continues, and mergers and acquisitions (M&As) remain hot.
Mar 01, 2008
BioPharm International
By BioPharm International Editors
Despite the rising fears about a slowing economy, the biotech industry will continue to maintain its momentum this year.
Nov 01, 2007
BioPharm International
By BioPharm International Editors
The biopharmaceutical sector can look forward to a financially flush venture funding environment in 2008
Feb 01, 2006
BioPharm International
By BioPharm International Editors
Like a snowball rolling down Mt. Everest, stem- cell research was gaining momentum, not only in political and medical arenas, but on Wall Street, too.
native1_300x100
lorem ipsum